An Observational Study on Real-world Use and Outcomes of Patients Treated With Tolvaptan for Hyponatraemia Due to SIADH

NCT02545101 · clinicaltrials.gov ↗

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyponatremia
Syndrome of Inappropriate ADH (SIADH) Secretion

Sponsor

Otsuka Pharmaceutical Europe Ltd